CD
Carl Dambkowski (Director) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $6.2M of ORKA (105,000 sh across 3 lots, as filed), executed May 21. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
12
0 buys · 12 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$17.7M
shares × price, as filed
Last traded
Aug 5
Filed Aug 7
Median ADV $371.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $19.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Sector per market data · by filing · past 12 months
Most traded names
APGERecent filings
APGESALE
Apogee Therapeutics, Inc.
View filing →
$738K5,500 sh × $134.17
Exec Aug 5
Filed Aug 7 · 8:00 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $730K
5,500 sh × $132.74
Exec Jul 1
Filed Jul 2 · 8:13 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $3.5M
26,400 sh × $132.60
Exec Jun 22
Filed Jun 24 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $2.5M
35,000 sh across 2 lots
Exec Jun 11
Filed Jun 12 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $433K
5,500 sh × $78.71
Exec Jun 3
Filed Jun 5 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $6.2M
105,000 sh across 3 lots
Exec May 21
Filed May 22 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $463K
5,500 sh across 2 lots
Exec May 6
Filed May 8 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $458K
5,400 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET More filings →